Australia, June 13 -- Bayer AG, owns the trademark (2536631) for 'HYRNUO' till Feb. 21, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations, for use in the following fields: treatment of oncological indications; pharmaceutical preparations, for use in the following fields: treatment and prevention of cardiovascular diseases; pharmaceutical preparations for use in the following fields: treatment and prevention of inflammatory indications; pharmaceutical preparations for use in the following fields: treatment of parkinson's disease.]
Type of Mark: Word
Date of Acceptance: April 4
Registration Advertised: June 12
For further details contact Christian Schalk.
The original document can be viewed at: https:/...